Reported Aug 9, 2017 · Terminated
Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.)…
Hospira a Pfizer Company
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hospira a Pfizer Company · 4285 N Wesleyan Blvd · Rocky Mount, NC · 27804-8612
Is this the product you have?
- Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.)
- one vial (NDC
0409-6629-02)b.) 25
- vial carton (NDC0409-6629-25)
- Lot codes and dates
- a.)
- one vial Lot74393EV Exp. 05/01/2018
- Lot75157EV Exp. 06/01/2018
- Lot
75367EVExp. 06/01/2018 b.) 25
- vial carton Lot
75158EVExp. 06/01/2018
- Amount recalled
- 15,034,600 10 mL multiple dose use vials
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
Why it was recalled
Lack of Sterility Assurance
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hospira a Pfizer Company recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.